Open AccessCarrageenan-Based Gel Retains Limited Anti-HIV-1 Activity 8–24 Hours After Vaginal Application by HIV-Infected Thai Women Enrolled in a Phase I Safety Trial
Jaids Journal Of Acquired Immune Deficiency SyndromesPeer ReviewedRichard E. Haaland +62012Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support